-+ 0.00%
-+ 0.00%
-+ 0.00%

VERVE THERAPEUTICS INC : BMO CUTS TO MARKET PERFORM FROM OUTPERFORM; CUTS TARGET PRICE TO $13.50 FROM $20.00

Reuters·06/27/2025 11:04:09

Please log in to view news